Invenomic Capital Management LP Tandem Diabetes Care Inc Transaction History

Invenomic Capital Management LP

  • $1.75 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$14.28 - $31.03 $448,934 - $975,521
-31,438 Reduced 11.54%
241,006 $7.13 Million
Q3 2023

Nov 14, 2023
BUY
$19.33 - $36.22 $3.68 Million - $6.89 Million
190,273 Added 231.56%
272,444 $5.66 Million
Q2 2023

Aug 14, 2023
BUY
$24.18 - $42.46 $1.99 Million - $3.49 Million
82,171 New
82,171 $2.02 Million

Others Institutions Holding TNDM

# of Institutions
354
Shares Held
71.9M
Call Options Held
3.36M
Put Options Held
229K
View Full List

About TANDEM DIABETES CARE INC

TNDM Quotes by TradingView
  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.28B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Invenomic Capital Management LP Portfolio

Follow Invenomic Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invenomic Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Invenomic Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email